Cardiol Therapeutics Inc. (CRDL) Total Assets by Year

CRDL

Cardiol Therapeutics Inc. closed fiscal year 2025 with $17.2M in total assets, $4.2M in total liabilities and $13.0M in shareholder equity. Total assets fell 22.2% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Cardiol Therapeutics Inc. has filed alongside them.

FY2025 annual

Total Assets $17.2M

Total Liabilities $4.2M

Total Equity $13.0M

YoY -22.2%

5Y CAGR +6.7%

Source SEC Filings (40-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Mar 31, 2026 Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CRDL Balance Sheet by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

Metric	FY2540-F	FY2440-F	FY2340-F	FY2240-F	FY2140-F	FY2040-F
Total Assets	$17.2M-22.2%	$22.1M-20.4%	$27.8M-39.4%	$45.8M-33.4%	$68.8M+451.9%	$12.5M
Total Liabilities	$4.2M-15.5%	$5.0M-22.6%	$6.4M-11.8%	$7.3M-20.3%	$9.1M+342.9%	$2.1M
Total Equity	$13.0M-24.1%	$17.2M-19.7%	$21.4M-44.5%	$38.6M-35.3%	$59.7M+473.4%	$10.4M

CRDL Balance Sheet by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

Metric	Q4'2540-F	Q4'2440-F	Q4'2340-F	Q4'2240-F	Q4'2140-F	Q4'2040-F
Total Assets	$17.2M-22.2%	$22.1M-20.4%	$27.8M-39.4%	$45.8M-33.4%	$68.8M+451.9%	$12.5M
Total Liabilities	$4.2M-15.5%	$5.0M-22.6%	$6.4M-11.8%	$7.3M-20.3%	$9.1M+342.9%	$2.1M
Total Equity	$13.0M-24.1%	$17.2M-19.7%	$21.4M-44.5%	$38.6M-35.3%	$59.7M+473.4%	$10.4M

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More Cardiol Therapeutics Inc. financials

Frequently Asked Questions

What was Cardiol Therapeutics Inc.'s total assets in fiscal year 2025?

Cardiol Therapeutics Inc. closed fiscal year 2025 with $17.2M in total assets, $4.2M in total liabilities and $13.0M in shareholder equity.

How fast is Cardiol Therapeutics Inc.'s total assets growing?

Cardiol Therapeutics Inc. (CRDL) total assets fell by 22.2% year over year, from $22.1M to $17.2M in fiscal year 2025.

How has Cardiol Therapeutics Inc.'s total assets changed over the years?

Across the 6 fiscal years this page covers, Cardiol Therapeutics Inc. (CRDL) total assets went from $12.5M in fiscal year 2020 to $17.2M in fiscal year 2025.

What was Cardiol Therapeutics Inc.'s total assets in the most recent quarter?

Cardiol Therapeutics Inc. (CRDL) reported $17.2M in total assets in Q4 2025. This represents a decrease of 22.2% from the same quarter a year earlier.

What does total assets mean on a financial statement?

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Cardiol Therapeutics Inc. (CRDL) reported on that line in every period on record.